Show simple item record

dc.contributor.authorMcMaster, Mitchell
dc.contributor.authorFielding, Elaine
dc.contributor.authorLim, David
dc.contributor.authorMoyle, Wendy
dc.contributor.authorBeattie, Elizabeth
dc.contributor.authorThe AusQoL Group
dc.date.accessioned2021-11-10T04:10:25Z
dc.date.available2021-11-10T04:10:25Z
dc.date.issued2018
dc.identifier.issn1741-203Xen_US
dc.identifier.doi10.1017/S1041610217002447en_US
dc.identifier.urihttp://hdl.handle.net/10072/410006
dc.description.abstractBackground: Behavioral and psychological symptoms of dementia (BPSD) are a common problem in long-term care facilities (LTC). Clinical guidelines dictate that first-line treatments for BPSD are psychosocial and behavioral interventions; if these are unsuccessful, psychotropic medications may be trialed at low doses and their effects can be monitored. Methods: There have previously been no studies with nationally representative samples to investigate psychotropic administration in LTCs in Australia. This study determines the prevalence of psychotropic administration in a representative stratified random sample of 446 residents living with dementia from 53 Australian LTCs. Questionnaire and medical chart data in this study is drawn from a larger cross-sectional, mixed methods study on quality of life in Australian LTCs. Results: It was found that 257 (58%) residents were prescribed psychotropic medications including: antipsychotics (n = 160, 36%), benzodiazepines (n = 136, 31%), antidepressants (n = 117, 26%), and anti-dementia medications (n = 9, 2%). BPSD were found to be very common in the sample, with 82% (n = 364) of participants experiencing at least one BPSD. The most prevalent BPSD were depression (n = 286, 70%) and agitation (n = 299, 67%). Conclusions: Although detailed background information was not collected on individual cases, the prevalence found is indicative of systematic industry-wide, over-prescription of psychotropic medications as a first-line treatment for BPSD. This study highlights a clear need for further research and interventions in this area.en_US
dc.description.peerreviewedYesen_US
dc.languageEnglishen_US
dc.publisherCambridge University Pressen_US
dc.publisher.placeUnited Kingdom
dc.relation.ispartofpagefrom1019en_US
dc.relation.ispartofpageto1026en_US
dc.relation.ispartofissue7en_US
dc.relation.ispartofjournalInternational Psychogeriatricsen_US
dc.relation.ispartofvolume30en_US
dc.subject.fieldofresearchBiomedical and clinical sciencesen_US
dc.subject.fieldofresearchPsychologyen_US
dc.subject.fieldofresearchcode32en_US
dc.subject.fieldofresearchcode52en_US
dc.subject.keywordsSocial Sciencesen_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsPsychology, Clinicalen_US
dc.subject.keywordsGeriatrics & Gerontologyen_US
dc.titleA cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: Issues of concernen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationMcMaster, M; Fielding, E; Lim, D; Moyle, W; Beattie, E; The AusQoL Group, A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: Issues of concern, International Psychogeriatrics, 2018, 30 (7), pp. 1019-1026en_US
dc.date.updated2021-11-10T04:03:53Z
gro.hasfulltextNo Full Text
gro.griffith.authorMoyle, Wendy


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record